...
首页> 外文期刊>Acta physiologica >International symposium on G-protein-coupled receptors (GPCRs), TRP (ion) channels and lipid signalling - GPCR-Helsinki 2010.
【24h】

International symposium on G-protein-coupled receptors (GPCRs), TRP (ion) channels and lipid signalling - GPCR-Helsinki 2010.

机译:G蛋白偶联受体(GPCR),TRP(离子)通道和脂质信号传导国际研讨会-GPCR-Helsinki 2010。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

G-protein-coupled receptors (GPCRs) are the major signalling entities for extracellular signalling molecules in intra-organism communication and chemosensation. GPCR functions have been known to the scientific world since the first seminal work of Langley and Loewi, among others, on the pharmacology and physiology, in the late 19th and early 20th century. With the refined pharmacological and biochemical methods, receptors and G-proteins could be specifically analysed, but the molecular isolation and finally exact molecular identification of the receptors, G-proteins and effectors was first initiated in the 1980s. Actually, as Robert Lefkowitz recollects, even that - for us obvious - fact that receptors or G-proteins exist as distinct molecular entities, was still in the 1970s doubted by many prominent scientists in the field (Lefkowitz 2007). The genomic and protein work and functional studies have since then revealed hundreds of GPCRs - with still quite a few without a known ligand - and almost 30 different Ga-subunits, together with a wide range of different downstream targets. GPCRs have also been suggested and shown to interact with and signal via other proteins than heterotrimeric G-proteins (Ritter & Hall 2009). Finally, GPCRs have risen to become the medically most important drug target.
机译:G蛋白偶联受体(GPCR)是生物体内通讯和化学传感中细胞外信号分子的主要信号实体。自19世纪末至20世纪初Langley和Loewi在药理学和生理学等方面的开创性工作以来,GPCR功能已为科学界所熟知。通过完善的药理和生化方法,可以特异性分析受体和G蛋白,但是在1980年代首次对受体,G蛋白和效应子进行了分子分离,最后进行了精确的分子鉴定。实际上,正如罗伯特·莱夫科维茨(Robert Lefkowitz)回忆的那样,即使在我们看来很明显,受体或G蛋白作为不同的分子实体存在,这一事实在1970年代仍然受到该领域许多著名科学家的质疑(Lefkowitz 2007)。从那时起,基因组和蛋白质研究以及功能研究揭示了数百种GPCR(还有相当一部分没有已知的配体)和近30种不同的Ga亚基,以及各种各样的下游靶标。还提出了GPCR,并显示GPCR与异三聚体G蛋白以外的其他蛋白相互作用并通过其发出信号(Ritter&Hall 2009)。最后,GPCR已成为医学上最重要的药物靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号